The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults
Launched by BUNDESWEHR UNIVERSITY MUNICH · Sep 19, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how hormonal contraceptive use and lifestyle factors, like physical activity and nutrition, affect bone health in young women, specifically female soldiers in the German armed forces. The researchers want to understand if different birth control methods, exercise habits, body composition, and other factors influence the risk of fractures and the overall quality of bones in women aged 18 to 35.
To participate, women need to be active soldiers within that age range and should not have any serious injuries affecting their muscles or bones. Participants will take part in evaluations that measure different aspects of their health, but they can do so using a pseudonym for privacy. This study is currently recruiting participants, and it aims to gather important information that could help improve bone health and reduce fracture risks in young women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 - 35 years
- • female
- • willing to participate under a pseudonym
- • occupational soldiers
- • free from chronic or acute musculoskeletal injury
- Exclusion Criteria:
- • for the bioelectrical impedance: electronic implants like defibrillator, pregnancy
About Bundeswehr University Munich
Bundeswehr University Munich, located in Germany, is a prominent institution dedicated to advancing research and education in the fields of medicine, engineering, and social sciences. As a clinical trial sponsor, the university leverages its interdisciplinary expertise to conduct innovative research aimed at improving healthcare outcomes for military personnel and the general population. Committed to ethical research practices and rigorous scientific methodologies, Bundeswehr University Munich collaborates with various stakeholders to facilitate groundbreaking studies that address critical health challenges, ensuring the highest standards of safety and efficacy in clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Munich, Bayern, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported